We invite patients with seropositive rheumatoid arthritis of moderate or high degree of disease activity and insufficient response to methotrexate monotherapy to participate in a clinical trial of a new form of tocilizumab
Opening of the center: biological therapy of rheumatoid arthritis
- Super User
- Trials
- Read Time: 1 min
- Hits: 0
Our partners
